Author Archives: lmo032

Public defence Week 13

Ingeborg BrønstadIngeborg Brønstad will have her public defence on Thursday March 26, 2015
Trial lecture: Thursday March 26, 2015, kl.09.15
Topic: ”Hva trenger vi å vite for å forstå hvordan HLA-molekyler bidrar til utvikling av autoimmune sykdommer”
Place: Auditorium 2, Bygg for biologiske basalfag, Jonas Lies Vei 91
Public defence: Thursday March 26, 2015, kl.11.15
Place: Auditorium 2, Bygg for biologiske basalfag, Jonas Lies Vei 91
Title of dissertation: ”Genetics of autoimmune Addison’s disease and congenital adrenal hyperplasia”
1st opponent Professor Anne Spurkland, Universitetet i Oslo
2nd opponent Førsteamanuensis Jørn Sagen, Universitetet i Bergen

 
press release

Public defence Week13

Tangvik Randi 04Randi Julie Tangvik will have her public defence on Wednesday March 25, 2015
Trial lecture: Wednesday March 25, 2015, kl.10.15
Topic: ”Implementering av ernæringsstrategier i norsk helsevesen ”
Place: Stort auditorium, 3. et. Sentralblokken, Haukeland Universitetssykehus
Public defence: Wednesday March 25, 2015, kl.12.15
Place: Stort auditorium, 3. et. Sentralblokken, Haukeland Universitetssykehus
Title of dissertation: ”Nutritional risk in a university hospital: Challenges and    consequences in clinical practice”
1st opponent Professor Henrik Højgaard Rasmussen, Aalborg Universitet
2nd opponent Ph.d. Lene Thoresen, St. Olavs Hospital, Trondheim

 Press release

Meetings/workshops/conferences

  1. DIA 27th Annual Euro meeting

Development, Innovation, Access and Patient Safety. Issues across the entire drug development value chain. 13-15 April 2015, Paris, France.

 2 Driving forces behind research and innovation. The Focus on Business Seminar 2015: From curiosity to success. Oslo, 21 April

 3 BIO-NANO match-making seminar for new joint Call on industry-relevant research in autumn 2015 (NANO2021 and BIONÆR). Oslo, 21 April

 4 Hvordan bli professor i Norge? Information and discussion about the path to professorship.

Oslo, 27 April

 New5. 10th NRI-Conference: Nordic Cooperation for Future Health and Challanges. Bergen, 4-5 May.

 6. Preannouncement: European IPR Helpdesk seminar “From Invention to Innovation” – Strategies for the Successful Exploitation. 12 – 13 May 2015, Bergen. More info comes here.

 New7. Webinar: Impact and Innovation in H2020 – a Guide for Proposers. 27 May 10.30-11.45. The registration will open 3 weeks in advance of the webinar.

 8. 2nd EATRIS conference: Building Bridges in Translational Medicine.

Amsterdam, 27-28 May 2015

 9 Conference EnGendering excellence. Gender is a cross-cutting issue in Horizon 2020. Distinguished international researchers will present why sex/gender analysis is crucial for the quality of their research. RCN, Oslo, 4-5 June 2015

 10. EuroNanoForum 2015: the largest European conference on nanotechnologies in the industrial environment offers excellent opportunities to find research and business contacts.

Riga, 10-12 June 2015

 11. 4th World Congress of Clinical Safety (4WCCS). Clinical Management and Governance for Healthcare Risk and Crisis. Vienna, Austria. 28 – 30 September 2015

 

 

 

New and simpler e-mail address for all employees

In order to simplify and adapt UiB’s e-mail system to new and improved services, abbreviation to unit/department/area will be removed from the e-mail addresses.  All new e-mail addresses will end with @uib.no.  All employees in the central administration have already obtained @uib.no, and on March 12 all other employees at UiB will also obtain the new e-mail address.  NB! The old e-mail address (@unit.uib.no) will still work!  Persons with similar names will be contacted by the IT-department either via e-mail or via phone.
Here you can read more about the Project (in Norwegian)

Public defence Week 11

Lisa Drange HoleLisa Drange Hole will have her public defence on Friday March 13, 2015
Trial lecture: Friday March 13, 2015, kl.09.15
Topic: ”Terapeutiske muligheter for å redusere toksiske effekter av medikamenter på hjertet ”
Place: Auditorium 1, Bygg for biologiske basalfag, Jonas Lies Vei 91
Public defence: Friday March 13, 2015, kl.11.15
Place: Auditorium 1, Bygg for biologiske basalfag, Jonas Lies Vei 91
Title of dissertation: ”Cardiotoxicity of Doxorubicin. A study of Methods and protective interventions in Rat Models”
1st opponent Professor Odd Brsrs, Universitetet i Oslo
2nd opponent Professor Ellen Aasum, Universitetet i Tromsø

 Press relase

 

Public defence Week 11

Liv Cecilie Vestrheim ThomsenLiv Cecilie Vestrheim Thomsen will have her public defence on Friday March 13, 2015
Trial lecture: Friday March 13, 2015, kl.09.15
Topic: ”The immune system’s response; a common denominator in preecampsia and cardiovascular disease”
Place: Kvinneklinikken auditorium, Jonas Lies Vei 72
Public defence: Friday March 13, 2015, kl.11.15
Place: Kvinneklinikken auditorium Jonas Lies Vei 72
Title of dissertation: ”Preeclampsia: Specific genetic risk factors and shared predisition with cardiovascular disease”
1st opponent Professor Stefan Hansson, Lunds Universitet, Sverige
2nd opponent Professor Kristian Hveem, NTNU, Trondheim

 press relase

Meetings/workshops/Conferences

  1. 1. European Summit on Innovation for Active and Healthy Ageing, Brussels 9-10 March 2015
  2. Nye metoder for prediksjon av negative helseeffekter som følge av miljøgifter. Litteraturhuset i Oslo, i regi av programmet Miljøpåvirkning og helse. 17 March 2015
  3. The 9th Conference on Global Health and Vaccination Research. How can research inform the post-2015 agenda for women’s and children’s health and rights? 17-18 March 2015, Oslo.
  4. DIA 27th Annual Euro MeetingDevelopment, Innovation, Access and Patient Safety. Issues across the entire drug development value chain. 13-15 April 2015, Paris, France.

NY! 5. Driving forces behind research and innovation. The Focus on Business Seminar 2015: From curiosity to success. Oslo, 21 April

NY! Lenke 6. BIO-NANO match-making seminar for new joint Call on industry-relevant research in autumn 2015 (NANO2021 and BIONÆR). Oslo, 21 April

NY! 7. Hvordan bli professor i Norge? Information and discussion about the path to professorship. Oslo, 27 April

  1. 2nd EATRIS conference: Building Bridges in Translational Medicine. Amsterdam 27-28 May 2015

Report from the Strategy Seminar

Eystein 2The Strategy Seminar last week was informative and useful. Vice Dean for Research at Karolinska Institutet (KI) Hans-Gustaf Ljunggren gave an engaging talk about KI’s research strategy. Their starting point was to acknowledge that KI did not excel in medical research to the degree that KI thought themselves. Systematic bibliographic analyses of publication activity revealed that they had a strong position in Europe, but several universities with which they liked to be compared to, did better. KI defined as its goal to become as good as University of Oxford with regards to “impact” of publications. To reach this goal they decided to publish fewer, but better articles – in other words, more articles that bring significant new knowledge to the field and therefore reach the most prestigious journals. KI viewed their PhD-programs’ demand for 3-4 articles as an obstacle – “it is better to publish one high-impact article than 3-4 articles of lesser importance”. KI has now removed the demand for a minimum number of articles in PhD-theses. Furthermore, KI wishes to recruit active research leaders and now work very actively with recruitment of such persons. A “starting package” often is in the order of 10 million per year for 3-5 years. Such a package is often composed of both university- and external funding, but it should be noted that KI is in charge of the strategy and the evaluation of candidates. At the same time KI has a keen eye also on the groups who perform badly, and take action. Sometimes such groups merged with stronger groups, other times they are dismantled.

 ViceRector Anne Lise Fimreite talked about UiB’s strategy process. UiB aims to build up strong research clusters. One of these is called Health, and will focus on research related to health services (Samhandlingsreformen). The strategy document will soon be out on hearing, which gives you a chance to submit your views.

 Finally the Pharmaceutical Industry informed of their interest in increased interaction with academic institutions; they wish to establish a pilot center for such collaboration in Bergen. It will be exciting to learn more about this in the near future.

 Finally there was a workshop and discussion on the department’s organization. I expected both criticism and creative suggestions for changes, but it appeared that most people were satisfied with today’s organization. The discussion was rather tame, but one conclusion emerged – if K2 is to improve we have to collaborate better; everyone must contribute to do the work.

 Eystein Husebye

 Head of Department

NEW K1/K2 SEMINAR 2015

We wish to invite everyone to the K1/K2 seminar series!

 Next seminar:
Title: “Genetic alterations causing resistance to chemotherapy in breast
cancer”
 Held by Stian Knappskog.
Section of Oncology, K2, UiB / Mohn Kreftforskningslab., HUS
When: Wednesday 4th of March, 14:15 – 15:00.
Where: Stort Auditorium, 3rd floor, Sentralblokken
Chair: Pål Njølstad

  Continue reading